10-K: Zimmer Biomet Amends Executive Severance Agreements to Align with Peer Practices

Zimmer Biomet has updated its executive change in control severance agreements to provide for either a reduction in payments to avoid excise tax or full payment, whichever results in a better after-tax outcome for the executive.

Summary

• Zimmer Biomet has amended its change in control severance agreements with certain executives.
• The amendments modify the tax provisions related to severance payments.
• Previously, severance payments would be reduced to avoid excise tax.
• Now, payments will either be reduced to avoid excise tax or paid in full, depending on which option provides the better after-tax result for the executive.
• The changes are intended to align with peer competitor practices.
• The amendments also clarify the order in which payments will be reduced if a reduction is necessary.

Sentiment

Score: 7

Explanation: The document reflects a positive change for executives, aligning with industry standards, but it also introduces a potential increase in costs for the company.

Positives

• The amendments provide a more favorable outcome for executives in the event of a change in control.
• The changes align Zimmer Biomet's practices with those of its peers.
• The amendments provide clarity on the order of payment reductions.

Risks

• The amendments could potentially increase the cost of severance payments in certain change of control scenarios.
• The amendments may not fully mitigate the risk of excise tax liability for executives.

Future Outlook

The amended agreements will continue in effect through December 31, 2024, with automatic one-year extensions unless either party provides written notice of non-renewal.

Industry Context

The amendments reflect a trend in executive compensation to provide more favorable terms to executives in change of control situations, aligning with peer practices in the industry.

Comparison to Industry Standards

• The amendments to the severance agreements are designed to align with observed peer competitor practices.
• Many companies in the medical device and pharmaceutical industries offer similar change in control protections to their executives.
• The specific terms of these agreements, such as the 'better net after-tax result' clause, are becoming more common in executive compensation packages.
• Companies like Johnson & Johnson, Stryker, and Medtronic, which are competitors of Zimmer Biomet, often have similar provisions in their executive severance agreements.

Stakeholder Impact

• Executives will benefit from the more favorable terms in the amended severance agreements.
• Shareholders may be concerned about the potential increase in costs associated with severance payments.
• The company aims to maintain competitive compensation practices to attract and retain top talent.

Next Steps

• The amended agreements will be in effect through December 31, 2024, with automatic one-year extensions unless either party provides written notice of non-renewal.
• The company will continue to monitor and adjust its executive compensation practices as needed.

Key Dates

Keywords

severance agreement, change in control, executive compensation, excise tax, peer practices, golden parachute, tax provisions